Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Gb Sciences Inc (OP:GBLX)

0.0005 UNCHANGED

Streaming Delayed Price Updated: 2:54 PM EST, Dec 29, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,527,347
Open	0.0005
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	0.0005
Today's Range	0.0005 - 0.0005
52wk Range	0.0001 - 0.0085
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Cannabis On Thanksgiving: 10 Science-Backed Benefits For A Happier Holiday ↗

November 27, 2024

Discover 10 science-backed cannabis benefits for Thanksgiving, from reducing stress to boosting appetite, mood, and sleep quality.

Via Benzinga

GB Sciences Signs Letter of Intent for a License to Develop and Market Their Cannabinoid-Based Parkinson’s Formulation With Endopure Life Sciences

July 02, 2024

Via ACCESSWIRE

Performance

YTD	-88.9%	-88.9%
1 Month	+66.7%	+66.7%
3 Month	+150.0%	+150.0%
6 Month	+66.7%	+66.7%
1 Year	-88.1%	-88.1%

More News

Gb Sciences’ Novel Parkinson’s Disease Medication is Featured on Worldwide Business with kathy ireland(R)

December 14, 2023

Via ACCESSWIRE

Gb Sciences' First-in-Class Parkinson's Disease Therapy Successfully Completes Dose Response Study at the University of Lethbridge

July 11, 2023

Via ACCESSWIRE

GB Sciences' First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson's Disease Has Been Issued in China

March 20, 2023

Via ACCESSWIRE

Successful 2022 Milestones Support Value of Gb Sciences' AI-Enabled Drug Discovery Platform

March 07, 2023

Via ACCESSWIRE

Marijuana And Chronic Pain: Gb Sciences' Nanoparticle Technology Boosts Efficacy Of Cannabis Terpenes ↗

March 29, 2022

Via Benzinga

Gb Sciences Identifies Novel Cannabis-Inspired Mixtures as Anti-Inflammatory Therapies Based on Proprietary AI-Enabled Drug Discovery Platform

December 22, 2022

Via Newswire.com

Gb Sciences Identifies Novel Cannabis-Inspired Mixtures as Anti-Inflammatory Therapies Based on Proprietary AI-Enabled Drug Discovery Platform

December 22, 2022

From Gb Sciences

Via GlobeNewswire

Gb Sciences Addresses Growing Need for Anxiety and Depression Medications With Non-Psychedelic, Kava-Based Formulations

December 12, 2022

Via Newswire.com

Gb Sciences Addresses Growing Need for Anxiety and Depression Medications With Non-Psychedelic, Kava-Based Formulations

December 12, 2022

From Gb Sciences

Via GlobeNewswire

Cannabis Terpenes Reduce Inflammation, Says Gb Sciences Study ↗

November 01, 2022

Via Benzinga

Gb Sciences Co-Publishes Study Demonstrating Anti-Inflammatory Properties of Cannabis Ingredients

November 01, 2022

Via Newswire.com

Gb Sciences' Plant-based Formulations Designed to Treat Anxiety Achieve Statistical Significance in Animal Study

October 24, 2022

Via Newswire.com

TODAY: Gb Sciences' President Demonstrates Effectiveness of Simplified Therapeutic Mixtures Inspired by Cannabis Plant Extracts at Canna Pharma 2022 Conference

October 13, 2022

Via Newswire.com

New Study Shows Promising Results In Treatment Of Parkinson's Disease With Cannabinoids ↗

October 10, 2022

Via Benzinga

Gb Sciences Co-Publishes Study Demonstrating Efficacy of Its Proprietary Cannabinoid Mixtures for the Treatment of Parkinson's Disease

October 10, 2022

Via Newswire.com

TODAY: Gb Sciences Describes Drug Development Progress in Pharma's Almanac Journal Article

September 06, 2022

Via Newswire.com

TODAY: Gb Sciences' President and Chief Science Officer Presents Keynote Address on Cannabinoid-Containing Formulations for Parkinson's Disease at 2022 NeuroForum Summit

May 23, 2022

Via Newswire.com

TODAY: Gb Sciences Showcases Its PhAROS™ Drug Discovery Platform at the 2nd ALCOR Drug Discovery Platform Summit

May 12, 2022

Via Newswire.com

TODAY: Gb Sciences' Novel Plant-Inspired Pain Medications Featured at SMi's 22nd Annual Pain Therapeutics Conference

May 05, 2022

Via Newswire.com

FHI Clinical to Write Clinical Trial Protocol for Development of Gb Sciences' COVID-19-Related, Anti-Inflammatory Therapies

May 02, 2022

Via Newswire.com

Gb Sciences To Begin Dosage Study For Cannabinoid-Containing Drug For Treatment Of Parkinson's Disease ↗

April 12, 2022

Via Benzinga

Gb Sciences to Begin Dosage Study for Its Novel Parkinson's Disease Formulations at the University of Lethbridge

April 12, 2022

Via Newswire.com

Gb Sciences' Nanoparticle Encapsulation Technology Improves the Efficacy of Terpenes for Use in Our Chronic Pain Formulations as Demonstrated in New Research Article

March 29, 2022

Via Newswire.com

Frequently Asked Questions

Is Gb Sciences Inc publicly traded?

Yes, Gb Sciences Inc is publicly traded.

What exchange does Gb Sciences Inc trade on?

Gb Sciences Inc trades on the OTC Traded

What is the ticker symbol for Gb Sciences Inc?

The ticker symbol for Gb Sciences Inc is GBLX on the OTC Traded

What is the current price of Gb Sciences Inc?

The current price of Gb Sciences Inc is 0.0005

When was Gb Sciences Inc last traded?

The last trade of Gb Sciences Inc was at 12/29/25 02:54 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.